Avaleht › 2. tüüpi diabeet › Maryland
2. tüüpi diabeet kliinilised uuringud osariigis Maryland
26 uuringut haiguse 2. tüüpi diabeet jaoks otsivad osalejaid osariigis Maryland.
Linnad osariigis Maryland
Ametlik uuringutekst (inglise keeles)
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Endo and Metabolic Consultants, Rockville
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07564414EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Ascension Saint Agnes Heart Care, Baltimore
- Medstar Montgomery Medical Center, Olney
- MD Medical Research, Oxon Hill
- ja veel 1
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Endocrine and Metabolic Consultants, Rockville
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07754461A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Flourish Bowie dba Flourish Research, Bowie
- KUR Research at CMP, Columbia
VärbamineTerved vabatahtlikud oodatud
Vanused 55 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT06112418A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Ascension Saint Agnes Heart Care, Baltimore
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Beltsville
- Research Site, Oxon Hill
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT07776509ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
- Johns Hopkins Pediatric Diabetes Center, Baltimore
Värbamine
Vanused 8–21 · Kõik sood · Uuendatud 23. sept 2026 · NCT05463289A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Centennial Medical Group, Columbia
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Beltsville
- Research Site, Lanham
- Research Site, Oxon Hill
- ja veel 1
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07784270Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
- National Institutes of Health Clinical Center, Bethesda
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 12–25 · Kõik sood · Uuendatud 17. sept 2026 · NCT06730113A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Bowie
- AURORA-2 Clinical Site, Rockville
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT07743450A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
- Research Site, Brooklyn
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 18–55 · Kõik sood · Uuendatud 16. sept 2026 · NCT07723833A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Privia Medical Group, LLC - Kelly's Collaborative Care - Javara - PPDS, Silver Spring
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 15. sept 2026 · NCT07340320A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Centennial Medical Group, Columbia
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. sept 2026 · NCT07351058A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- MD Medical Research, Oxon Hill
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 11. sept 2026 · NCT07668388A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Rockville
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Velocity Clinical Research, Rockville, Rockville
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT07296484AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Ascension Saint Agnes Heart Ca, Baltimore
- MedStar Good Samaritan Hosp, Baltimore
VärbamineFaas 3
Vanused 45 ja vanemad · Kõik sood · Uuendatud 1. sept 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Annapolis
- Research Site, Lutherville-Timonium
- Research Site, Oxon Hill
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 31. aug 2026 · NCT07662109A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Bowie
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 31. aug 2026 · NCT07662044Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- Baltimore VA Medical Center Univ of Maryland, Baltimore
Värbamine
Vanused 18–80 · Kõik sood · Uuendatud 28. aug 2026 · NCT07599982A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Research Site, Potomac
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. aug 2026 · NCT07606066A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Johns Hopkins University School of Medicine, Baltimore
VärbamineFaas 3
Vanused 10–17 · Kõik sood · Uuendatud 7. aug 2026 · NCT06739122A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Research Site, Potomac
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. aug 2026 · NCT07664553DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- Johns Hopkins University School of Medicine, Baltimore
VärbamineVaatlusuuring
Vanused 8–15 · Kõik sood · Uuendatud 7. mai 2026 · NCT06525259Groceries Plus Multi-Component Lifestyle Intervention for Adults With Hypertension and Type 2 Diabetes
- Johns Hopkins ProHealth Clinical Research Unit, Baltimore
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 24. märts 2026 · NCT06921356Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.